|
1.
|
World Health Organization: Informe sobre
la salud en el mundo. Technical Report.WHO; Geneva, Switzerland:
2002
|
|
2.
|
Jackson CF and Wenger NK: Cardiovascular
disease in the elderly. Rev Esp Cardiol. 64:697–712.
2011.PubMed/NCBI
|
|
3.
|
Palomo I, Toro C and Alarcón M: The role
of platelets in the pathophysiology of atherosclerosis (Review).
Mol Med Rep. 1:179–184. 2008.PubMed/NCBI
|
|
4.
|
Palomo I, Alarcón M, Moore-Carrasco R and
Argilés J: Hemostasis alterations in metabolic syndrome (Review).
Int J Mol Med. 18:969–974. 2006.PubMed/NCBI
|
|
5.
|
Palomo I, Torres G, Alarcon M, Maragaño P,
Leiva E and Mujica V: Alta prevalencia de factores de riesgo
cardiovascular clásicos en una población de estudiantes
universitarios de la región centro-sur de Chile. Rev Esp Cardiol.
59:1099–1105. 2006.PubMed/NCBI
|
|
6.
|
Palomo I, Icaza G, Mujica V, et al:
Prevalencia de factores de riesgo cardiovascular clásicos en
población adulta de Talca, Chile, 2005. Rev Med Chile. 135:904–912.
2007.PubMed/NCBI
|
|
7.
|
Lubos E, Handy D and Loscalzo J: Role of
oxidative stress and nitric oxide in atherothrombosis. Front
Biosci. 13:5323–5344. 2009.PubMed/NCBI
|
|
8.
|
Badimón L, Vilahur G and Padró T:
Lipoproteínas, plaquetas y aterotrombosis. Rev Esp Cardiol.
62:1161–1178. 2009.
|
|
9.
|
Roldán I: Nuevos antiagregantes en el
síndrome coronario agudo. El futuro es hoy Rev Esp Cardiol Suppl.
10:12D–22D. 2010.
|
|
10.
|
Santos M, Aranda E, Vallés J and Palomo I:
Hemostasia primaria. Hematología: Fisiopatología y Diagnóstico.
Palomo I, Pereira J and Palma J: Editorial Universidad de Talca;
Talca: pp. 459–492. 2005
|
|
11.
|
Zhang J, Blackmore PF, Hargrave BY, Xiao
S, Beebe SJ and Schoenbach KH: Nanosecond pulse electric field
(nanopulse): a novel non-ligand agonist for platelet activation.
Arch Biochem Biophys. 471:240–248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Panes O, Matus V, Sáez CG, Quiroga T,
Pereira J and Mezzano D: Human platelets synthesize and express
functional tissue factor. Blood. 109:5242–5250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Aukrust P, Halvorsen B, Ueland T, et al:
Activated platelets and atherosclerosis. Expert Rev Cardiovasc
Ther. 8:1297–1307. 2010. View Article : Google Scholar
|
|
14.
|
Dauchet L, Amouyel P, Hercberg S and
Dallongeville J: Fruit and vegetable consumption and risk of
coronary heart disease: a meta-analysis of cohort studies. J Nutr.
136:2588–2593. 2006.PubMed/NCBI
|
|
15.
|
Koleckar V, Brojerova E, Rehakova Z, et
al: In vitro antiplatelet activity of flavonoids from Luzea
carthamoides. Drug Chem Toxicol. 31:27–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Khan AN, Fatima I, Khaliq UA, Malik A,
Miana GA, Qureshi ZU and Rasheed H: Potent anti-platelet
constituents from Centaurea iberica. Molecules.
16:2053–2064. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Palomo I, Moore-Carrasco R, Carrasco G,
Villalobos P and Guzmán L: El consumo de tomates previene el
desarrollo de enfermedades cardiovasculares y cáncer: antecedentes
epidemiológicos y mecanismos de acción. Idesia. 28:121–129.
2010.
|
|
18.
|
Silverstein R: Inflammation,
atherosclerosis, and arterial thrombosis: role of the scavenger
receptor CD36. Cleve Clin J Med. 76:S27–S30. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Nesbitt WS, Westein E, Tovar-Lopez FJ, et
al: A shear gradient-dependent platelet aggregation mechanism
drives thrombus formation. Nat Med. 15:665–673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Lindemann S, Kramer B, Seizer P and Gawaz
M: Platelets, inflammation and atherosclerosis. J Thromb Haemost.
5:203–211. 2007. View Article : Google Scholar
|
|
21.
|
Cimmino G, D’Amico C, Vaccaro V, D’Anna M
and Golino P: The missing link between atherosclerosis,
inflammation and thrombosis: is it tissue factor? Expert Rev
Cardiovasc Ther. 9:517–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Verhamme P and Hoylaerts M: The pivotal
role of the endothelium in haemostasis and thrombosis. Acta Clinica
Belgica. 61:213–219. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Rau JC, Beaulieu LM, Huntington JA and
Church FC: Serpins in thrombosis, hemostasis and fibrinolysis. J
Thromb Haemost. 5:102–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Van Gils J, Zwaginga J and Hordijk P:
Molecular and functional interactions among monocytes, platelets,
and endothelial cells and their relevance for cardiovascular
diseases. J Leukoc Biol. 85:195–204. 2009.PubMed/NCBI
|
|
25.
|
Palomo I, Torres C, Moore-Carrasco R,
Alarcón M and Maragaño P: Platelet anti-aggregants: mechanisms of
action and use-associated risks. Vitae. 16:133–143. 2009.
|
|
26.
|
Schober A: Chemokines in vascular
dysfunction and remodeling. Arterioscler Thromb Vasc Biol.
28:1950–1959. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Badimón JJ, Santos-Gallego C, Torres F,
Castillo J and Kaski J: Nuevas herramientas en la estratificación
del riesgo cardiovascular. Rev Esp Cardiol Suppl. 11(B): 21–28.
2011.
|
|
28.
|
Lievens D, Zernecke A, Seijkens T, et al:
Platelet CD40L mediates thrombotic and inflammatory processes in
atherosclerosis. Blood. 116:4317–4327. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Martín M, Rodríguez I, Palacín M and Coto
E: Polimorfismos de metaloproteasas y válvula aórtica bicúspide.
Rev Esp Cardiol. 63:1382–1389. 2010.
|
|
30.
|
Lievens D, Eijgelaar WJ, Biessen EA,
Daemen MJ and Lutgens E: The multi-functionality of CD40L and its
receptor CD40 in atherosclerosis. Thromb Haemost. 102:206–214.
2009.PubMed/NCBI
|
|
31.
|
Giannini S, Falcinelli E, Bury L,
Guglielmini G, Rossi R, Momi S and Gresele P: Interaction with
damaged vessel wall in vivo in humans induces platelets to
express CD40L resulting in endothelial activation. No effect of
aspirin intake. Am J Physiol Heart Circ Physiol. 300:2072–2079.
2011.
|
|
32.
|
Gleissner C, Von Hundelshausen P and Ley
K: Platelet chemokines in vascular disease. Arterioscler Thromb
Vasc Biol. 28:1920–1927. 2008. View Article : Google Scholar
|
|
33.
|
Totani L and Evangelista V:
Platelet-leukocyte interactions in cardiovascular disease and
beyond. Arterioscler Thromb Vasc Biol. 30:2357–2361. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Semple J, Italiano J and Freedman J:
Platelets and the immune continuum. Nat Rev Immunol. 11:264–274.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Siegel-Axel D and Gawaz M: Platelets and
endothelial cells. Semin Thromb Hemost. 33:128–135. 2007.
View Article : Google Scholar
|
|
36.
|
Von Hundelshausen P and Weber C: Platelets
as immune cells: bridging inflammation and cardiovascular disease.
Circ Res. 100:27–40. 2007.PubMed/NCBI
|
|
37.
|
Badimon L, Storey R and Vilahur G: Update
on lipids, inflammation and atherothrombosis. Thromb Haemost.
105:S34–S42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Zineh I, Beitelshees AL, Welder GJ, et al:
Epithelial neutrophilactivating peptide (ENA-78), acute coronary
syndrome prognosis, and modulatory effect of statins. PLoS One.
3:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Zernecke A, Shagdarsuren E and Weber C:
Chemokines in atherosclerosis. Arterioscler Thromb Vasc Biol.
28:1897–1908. 2008. View Article : Google Scholar
|
|
40.
|
An G, Wang H, Tang R, et al: P-Selectin
glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and
a major determinant for Ly-6Chi monocyte recruitment to sites of
atherosclerosis in mice. Circulation. 117:3227–3237. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Cha BY, Shi WL, Yonezawa T, Teruya T,
Nagai K and Woo JT: An inhibitory effect of chrysoeriol on
platelet-derived growth factor (PDGF)-induced proliferation and
PDGF receptor signaling in human aortic smooth muscle cells. J
Pharmacol Sci. 110:105–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Vestweber D, Broermann A and Schulte D:
Control of endothelial barrier function by regulating vascular
endothelial-cadherin. Curr Opin Hematol. 17:230–236. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Komarova Y and Malik A: Regulation of
endothelial permeability via paracellular and transcellular
transport pathways. Annu Rev Physiol. 72:463–493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Rojas A and Morales-Segura M: Nitric
oxide, an iceberg in cardiovascular physiology: far beyond vessel
tone control. Arch Med Res. 35:1–11. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Jennings L: Mechanisms of platelet
activation: need for new strategies to protect against
platelet-mediated atherothrombosis. Thromb Haemost. 102:248–257.
2009.PubMed/NCBI
|
|
46.
|
Badimon L and Martínez-González J:
Disfunción endotelial. Rev Esp Cardiol Suppl. 6:21A–30A.
2006.PubMed/NCBI
|
|
47.
|
Badimon L, Martinez-Gonzalez J,
Llorente-Cortes V, Rodriguez C and Padro T: Cell biology and
lipoproteins in atherosclerosis. Curr Mol Med. 6:439–456. 2006.
View Article : Google Scholar
|
|
48.
|
Deanfield J, Halcox J and Rabelink T:
Endothelial function and dysfunction: testing and clinical
relevance. Circulation. 115:1285–1295. 2007.PubMed/NCBI
|
|
49.
|
Martinez-Gonzalez J and Badimon L:
Influence of statin use on endothelial function: from bench to
clinics. Curr Pharm Des. 13:1771–1786. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Palomo I, Moore-Carrasco R, Alarcon M,
Rojas A, Espana F, Andres V and Gonzalez-Navarro H: Pathophysiology
of the proatherothrombotic state in the metabolic syndrome. Front
Biosci. 2:194–208. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Matsumoto T, Kobayashi T and Kamata K:
Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med
Chem. 14:3209–3220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Erdogan A, Schaefer MB, Kuhlmann CR, et
al: Activation of Ca2+ activated potassium channels is
involved in lysophosphatidylcholine-induced monocyte adhesion to
endothelial cells. Atherosclerosis. 190:100–105. 2007.
|
|
53.
|
Zou Y, Kim CH, Chung JH, et al:
Upregulation of endothelial adhesion molecules by
lysophosphatidylcholine. Involvement of G protein-coupled receptor
GPR4. FEBS J. 274:2573–2584. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Kim EA, Kim JA, Park MH, Jung SC, Suh SH,
Pang MG and Kim YJ: Lysophosphatidylcholine induces endothelial
cell injury by nitric oxide production through oxidative stress. J
Matern Fetal Neonatal Med. 22:325–331. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Barbaux S, Poirier O, Pincet F, Hermand P,
Tiret L and Deterre P: The adhesion mediated by the P-selectin
P-selectin glycoprotein ligand-1 (PSGL-1) couple is stronger for
shorter PSGL-1 variants. J Leukoc Biol. 87:727–734. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Ruggeri Z and Mendolicchio L: Adhesion
mechanisms in platelet function. Circ Res. 100:1673–1685. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Lu D, Scully M, Kakkar V and Lu X: ADAM-15
disintegrin-like domain structure and function. Toxins.
2:2411–2427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Charrier-Hisamuddin L, Laboisse C and
Merlin D: ADAM-15: a metalloprotease that mediates inflammation.
FASEB J. 22:641–653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Badimon L and Vilahur G: Platelets,
arterial thrombosis and cerebral ischemia. Cerebrovasc Dis.
24:30–39. 2007. View Article : Google Scholar
|
|
60.
|
World Health Organization: Joint WHO/FAO
Expert Consultation on Diet, Nutrition, and the Prevention of
Chronic Diseases. WHO; Geneva, Switzerland: 2003
|
|
61.
|
He FJ, Nowson CA, Lucas M and MacGregor
GA: Increased consumption of fruit and vegetables is related to a
reduced risk of coronary heart disease: meta-analysis of cohort
studies. J Hum Hypertens. 21:717–728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Iqbal R, Anand S, Ounpuu S, et al: Dietary
patterns and the risk of acute myocardial infarction in 52
countries: results of the INTERHEART study. Circulation.
118:1929–1937. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Carlsen MH, Halvorsen BL, Holte K, et al:
The total antioxidant content of more than 3100 foods, beverages,
spices, herbs and supplements used worldwide. Nutr J. 9:1–11. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Lako J, Trenerry V, Wahlqvist M,
Wattanapenpaiboon N, Sotheeswaran S and Premier R: Phytochemical
flavonols, carotenoids and the antioxidant properties of a wide
selection of Fijian fruit, vegetables and other readily available
foods. Food Chem. 101:1727–1741. 2007. View Article : Google Scholar
|
|
65.
|
Badimon L, Vilahur G and Padro T:
Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther.
28:202–215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66.
|
Badimon L and Vilahur G: Enfermedad
aterotrombótica coronaria: avances en el tratamiento
antiplaquetario. Rev Esp Cardiol. 61:501–513. 2008.
|
|
67.
|
Palomo I, Gutiérrez M, Astudillo L, et al:
Efecto antioxidante de frutas y hortalizas de la zona central de
Chile. Rev Chil Nutr. 36:152–158. 2009. View Article : Google Scholar
|
|
68.
|
Dauchet L, Péneau S, Bertrais S, et al:
Relationships between different types of fruit and vegetable
consumption and serum concentrations of antioxidant vitamins. Br J
Nutr. 100:633–641. 2008. View Article : Google Scholar
|
|
69.
|
Palomo I, Yuri J, Moore-Carrasco R,
Quilodrán A and Neira A: El consumo de manzanas contribuye a
prevenir el desarrollo de enfermedades cardiovasculares y cáncer:
antecedentes epidemiológicos y mecanismos de acción. Rev Chil Nutr.
37:377–385. 2010.
|
|
70.
|
Pierre S, Crosbie L and Duttaroy A:
Inhibitory effect of aqueous extracts of some herbs on human
platelet aggregation in vitro. Platelets. 16:469–473. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Torres-Urrutia C, Guzmán L,
Schmeda-Hirschmann G, et al: Antiplatelet, anticoagulant, and
fibrinolytic activity in vitro of extracts from selected fruits and
vegetables. Blood Coagul Fibrinolysis. 22:197–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
Nuez F: El cultivo del tomate. Editorial
Mundi-Prensa; Barcelona: pp. 16–20. 1995
|
|
73.
|
Mekhfi H, Gadi D, Bnouham M, Ziyyat A,
Legssyer A and Aziz M: Effect of argan oil on platelet aggregation
and bleeding time: a beneficial nutritional property. J Complement
Integr Med. 5:1–18. 2008. View Article : Google Scholar
|
|
74.
|
Palomo I, Fuentes E, Carrasco G, González
D and Moore-Carrasco R: Actividad antioxidante, hipolipemiante y
antiplaquetaria del tomate (Solanum lycopersicum L.), y el
efecto de su procesamiento y almacenaje. Rev Chil Nutr. 37:524–533.
2010. View Article : Google Scholar
|
|
75.
|
Dutta-Roy A, Crosbie L and Gordon M:
Effects of tomato extract on human platelet aggregation in vitro.
Platelets. 12:218–227. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
76.
|
Lazarus S, Dutta-Roy A and Garg M: Aqueous
tomato extract inhibits platelet aggregation. Asia Pac J Clin Nutr.
11(Suppl): S2402002.
|
|
77.
|
Yamamoto J, Taka T, Yamada K, et al:
Tomatoes have natural anti-thrombotic effects. Br J Nutr.
90:1031–1038. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
78.
|
Fuentes E, Astudillo L, Gutiérrez M, et
al: Fractions of aqueous and methanolic extracts from tomato
(Solanum lycopersicum L.) present platelet antiaggregant
activity. Blood Coagul Fibrinolysis. 23:109–117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
79.
|
Lazarus S and Garg M: Tomato extract
inhibits human platelet aggregation in vitro without increasing
basal cAMP levels. Int J Food Sci Nutr. 55:249–256. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
80.
|
O’Kennedy N, Crosbie L, van Lieshout M,
Broom JI, Webb DJ and Duttaroy AK: Effects of antiplatelet
components of tomato extract on platelet function in vitro and ex
vivo: a time-course cannulation study in healthy humans. Am J Clin
Nutr. 84:570–579. 2006.PubMed/NCBI
|
|
81.
|
O’Kennedy N, Crosbie L, Whelan S, et al:
Effects of tomato extract on platelet function: a double-blinded
crossover study in healthy humans. Am J Clin Nutr. 84:561–569.
2006.PubMed/NCBI
|
|
82.
|
Provesi J, Odebrecht C and Amante E:
Changes in carotenoids during processing and storage of pumpkin
puree. Food Chem. 128:195–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83.
|
Nguyen ML and Schwartz SJ: Lycopene:
chemical and biological properties. Food Technol. 58:38–44.
1999.
|
|
84.
|
Shi J and Le M: Lycopene in tomatoes:
chemical and physical properties affected by food processing. Crit
Rev Biotechnol. 20:293–334. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
85.
|
Agrawal H, Kaul N, Paradkar AR and Mahadik
KR: Stability indicating HPTLC determination of clopidogrel
bisulphate as bulk drug and in pharmaceutical dosage form. Talanta.
61:581–589. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
86.
|
Lazarus S, Bowen K and Garg M: Tomato
juice and platelet aggregation in type 2 diabetes. JAMA.
292:805–806. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
87.
|
Murphy K, Chronopoulos A, Singh I, et al:
Dietary flavanols and procyanidin oligomers from cocoa
(Theobroma cacao) inhibit platelet function. Am J Clin Nutr.
77:1466–1473. 2003.PubMed/NCBI
|
|
88.
|
Born G and Cross M: The aggregation of
blood platelets. J Physiol. 168:178–195. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
89.
|
Unsworth AJ, Smith H, Gissen P, Watson SP
and Pears CJ: Submaximal inhibition of protein kinase c restores
ADP-induced dense granule secretion in platelets in the presence of
Ca2+. J Biol Chem. 286:21073–21082. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
90.
|
Kim S, Jin J and Kunapuli S: Akt
activation in platelets depends on Gi signaling pathways. J Biol
Chem. 279:4186–4195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
91.
|
Guidetti GF, Bernardi B, Consonni A, Rizzo
P, Gruppi C, Balduini C and Torti M: Integrin α2β1 induces
phosphorylation-dependent and phosphorylation-independent
activation of phospholipase Cγ2 in platelets: role of Src kinase
and Rac GTPase. J Thromb Haemost. 7:1200–1206. 2009.
|
|
92.
|
Kim SD, Lee IK, Lee WM, et al: The
mechanism of anti-platelet activity of davallialactone: involvement
of intracellular calcium ions, extracellular signal-regulated
kinase 2 and p38 mitogen-activated protein kinase. Eur J Pharmacol.
584:361–367. 2008. View Article : Google Scholar
|
|
93.
|
Liu FC, Liao CH, Chang YW, Liou JT and Day
YJ: A new insight of anti-platelet effects of sirtinol in platelet
aggregation via cyclic AMP phosphodiesterase. Biochem Pharmacol.
77:1364–1373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
94.
|
Ferreiro J, Gómez-Hospital J, Angiolillo D
and Cequier A: Los nuevos antagonistas del receptor P2Y12 pueden
reemplazar a los inhibidores de la glucoproteína IIb/IIIa? Rev Esp
Cardiol Suppl. 11(A): 14–19. 2011.
|
|
95.
|
Angiolillo DJ and Ferreiro JL: Platelet
adenosine diphosphate P2Y12 receptor antagonism: benefits and
limitations of current treatment strategies and future directions.
Rev Esp Cardiol. 63:60–76. 2010.
|
|
96.
|
Olas B, Wachowicz B, Tomczak A, Erler J,
Stochmal A and Oleszek W: Comparative anti-platelet and antioxidant
properties of polyphenol-rich extracts from: berries of Aronia
melanocarpa, seeds of grape and bark of Yucca schidigera
in vitro. Platelets. 19:70–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
97.
|
Spiel AO, Gilbert JC and Jilma B: Von
Willebrand factor in cardiovascular disease: focus on acute
coronary syndromes. Circulation. 117:1449–1459. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
98.
|
Fernández-Ortiz A, Núñez-Gil I,
Ruiz-Mateos B and Ibáñez B: Propiedades de los diferentes
inhibidores de la glucoproteína IIb/ IIIa: se puede aceptar el
efecto de clase? Rev Esp Cardiol Supl. 11:3–7. 2011.
|
|
99.
|
Paran E, Novack V, Engelhard YN and
Hazan-Halevy I: The effects of natural antioxidants from tomato
extract in treated but uncontrolled hypertensive patients.
Cardiovasc Drugs Ther. 23:145–151. 2009. View Article : Google Scholar
|
|
100.
|
Silaste ML, Alfthan G, Aro A, Kesäniemi YA
and Hörkkö S: Tomato juice decreases LDL cholesterol levels and
increases LDL resistance to oxidation. Br J Nutr. 98:1251–1258.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
101.
|
Kim JY, Paik JK, Kim OY, Park HW and Lee
JH, Jang Y and Lee JH: Effects of lycopene supplementation on
oxidative stress and markers of endothelial function in healthy
men. Atherosclerosis. 215:189–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
102.
|
Hung CF, Huang TF, Chen BH, Shieh JM, Wu
PH and Wu WB: Lycopene inhibits TNF-alpha-induced endothelial
ICAM-1 expression and monocyte-endothelial adhesion. Eur J
Pharmacol. 586:275–282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
103.
|
Cavallini C, Trettene M, Degan M, Delva P,
Molesini B, Minuz P and Pandolfini T: Anti-angiogenic effects of
two cystine-knot miniproteins from tomato fruit. Br J Pharmacol.
162:1261–1273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104.
|
Lee D, Grantham R, Mannion J and Trachte
A: Carotenoids enhance phosphorylation of Akt and suppress tissue
factor activity in human endothelial cells. J Nutr Biochem.
17:780–786. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
105.
|
Palozza P, Simone R, Catalano A, et al:
Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell
cycle arrest and apoptosis in human macrophages. J Nutr Biochem.
21:34–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
106.
|
Santangelo C, Varì R, Scazzocchio B, Di
Benedetto R, Filesi C and Masella R: Polyphenols, intracellular
signalling and inflammation. Ann Ist Super Sanita. 43:394–405.
2007.PubMed/NCBI
|
|
107.
|
Wood L and Gibson P: Dietary factors lead
to innate immune activation in asthma. Pharmacol Ther. 123:37–53.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
108.
|
Tang X, Yang X, Peng Y, Peng Y and Lin J:
Protective effects of lycopene against
H2O2-induced oxidative injury and apoptosis
in human endothelial cells. Cardiovasc Drugs Ther. 23:439–448.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
109.
|
Palozza P, Parrone N, Simone R and
Catalano A: Lycopene in atherosclerosis prevention: an integrated
scheme of the potential mechanisms of action from cell culture
studies. Arch Biochem Biophys. 504:26–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
110.
|
Simone R, Russo M, Catalano A, Monego G,
Froehlich K, Boehm V and Palozza P: Lycopene inhibits
Nf-κB-mediated IL-8 expression and changes Redox and PPARγ
signalling in cigarette smoke-stimulated macrophages. PLoS One.
6:1–11. 2011.
|
|
111.
|
Stangl V, Kuhn C, Hentschel S, et al: Lack
of effects of tomato products on endothelial function in human
subjects: results of a randomised, placebo-controlled cross-over
study. Br J Nutr. 105:263–267. 2011. View Article : Google Scholar
|
|
112.
|
McCarty M: Scavenging of
peroxynitrite-derived radicals by flavonoids may support
endothelial NO synthase activity, contributing to the vascular
protection associated with high fruit and vegetable intakes. Med
Hypotheses. 70:170–181. 2008. View Article : Google Scholar
|
|
113.
|
Weseler A and Bast A: Oxidative stress and
vascular function: implications for pharmacologic treatments. Curr
Hypertens Rep. 12:154–161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
114.
|
Duran X, Vilahur G and Badimon L:
Exogenous in vivo NO-donor treatment preserves p53 levels and
protects vascular cells from apoptosis. Atherosclerosis.
205:101–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
115.
|
Choi J, Choi Y, Shin S, et al: Dietary
flavonoids differentially reduce oxidized LDL-induced apoptosis in
human endothelial cells: role of MAPK- and JAK/STAT-signaling. J
Nutr. 138:983–990. 2008.
|
